SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
68 hedge funds and large institutions have $28M invested in Seelos Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
Holders
68
Holding in Top 10
–
Calls
$1.05M
Puts
$512K
Top Buyers
| 1 | +$747K | |
| 2 | +$114K | |
| 3 | +$107K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$107K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$93K |
Top Sellers
| 1 | -$986K | |
| 2 | -$843K | |
| 3 | -$689K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$478K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$475K |